Greenleaf Trust reports 12.88% increase in ownership of BRM / Bristol-Myers Squibb Company

Bristol-Myers Squibb Company

DE ˙ XTRA ˙ US1101221083

47,44 € ↑0,88 (1,88%)

2026-06-03
DEL PRIS

Security	DE:BRM / Bristol-Myers Squibb Company
Institution	Greenleaf Trust
Latest Disclosed Ownership	22,509 shares
Latest Disclosed Value	$ 1,365,171

On April 27, 2026 - Greenleaf Trust filed a 13F-HR form disclosing ownership of 22,509 shares of Bristol-Myers Squibb Company (DE:BRM) valued at $1,179,922 USD as of March 31, 2026. The entity filed a previous 13F-HR on January 21, 2026 disclosing 19,941 shares of Bristol-Myers Squibb Company. This represents a change in shares of 12.88% during the quarter. The current value of the position is $1,067,714 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel Premium Registration Required .

Disclosed Equity Positions (from 13F/NPORT Filings)

File Date	Effective Date	Form	Security	Class	ID	Reported Shares	ΔShares	ΔShares (%)	Reported Value (x1000)	ΔValue (%)	Alloc (%)
2026-04-27	2026-03-31	13F	Bristol Myers Squibb	Com	110122108	22,509	2,568	12.88	1,365	26.98	0.0075
2026-01-21	2025-12-31	13F	Bristol Myers Squibb	Com	110122108	19,941	-1,899	-8.70	1,076	9.25	0.0099
2025-10-22	2025-09-30	13F	Bristol Myers Squibb	Com	110122108	21,840	-4,363	-16.65	985	-18.81	0.0090
2025-07-17	2025-06-30	13F	Bristol Myers Squibb	Com	110122108	26,203	-4,976	-15.96	1,213	-36.24	0.0107
2025-04-30	2025-03-31	13F	Bristol Myers Squibb	Com	110122108	31,179	1,002	3.32	1,902	11.43	0.0173
2025-01-24	2024-12-31	13F	Bristol Myers Squibb	COM	110122108	30,177	4,576	17.87	1,707	28.85	0.0155
2024-10-22	2024-09-30	13F	Bristol Myers Squibb	COM	110122108	25,601	9,001	54.22	1,325	92.16	0.0118
2024-07-22	2024-06-30	13F	Bristol Myers Squibb	COM	110122108	16,600	-17,143	-50.80	689	-62.33	0.0065
2024-04-29	2024-03-31	13F	Bristol Myers Squibb	COM	110122108	33,743	-20,148	-37.39	1,830	-33.85	0.0170
2024-01-31	2023-12-31	13F	Bristol Myers Squibb	COM	110122108	53,891	-19,419	-26.49	2,765	-35.00	0.0296
2023-11-09	2023-09-30	13F	Bristol Myers Squibb	COM	110122108	73,310	5,305	7.80	4,255	-2.16	0.0491
2023-08-09	2023-06-30	13F	Bristol Myers Squibb	COM	110122108	68,005	-4,457	-6.15	4,349	-13.42	0.0462
2023-05-11	2023-03-31	13F	Bristol Myers Squibb	COM	110122108	72,462	3,027	4.36	5,022	125,450.00	0.0568
2023-01-25	2022-12-31	13F	Bristol Myers Squibb	COM	110122108	69,435	5,870	9.23	5	-99.91	0.0633
2022-11-10	2022-09-30	13F	Bristol Myers Squibb	COM	110122108	63,565	13,711	27.50	4,519	17.71	0.0669
2022-08-12	2022-06-30	13F	Bristol Myers Squibb	COM	110122108	49,854	10,328	26.13	3,839	32.98	0.0581
2022-04-27	2022-03-31	13F	Bristol Myers Squibb	COM	110122108	39,526	11,430	40.68	2,887	64.78	0.0345
2022-02-11	2021-12-31	13F	Bristol Myers Squibb	COM	110122108	28,096	-9,895	-26.05	1,752	-22.06	0.0205
2021-11-12	2021-09-30	13F	Bristol Myers Squibb	COM	110122108	37,991	-1,169	-2.99	2,248	-14.10	0.0274
2021-08-10	2021-06-30	13F	Bristol Myers Squibb	COM	110122108	39,160	2,611	7.14	2,617	13.44	0.0324
2021-04-30	2021-03-31	13F	Bristol Myers Squibb	COM	110122108	36,549	1,776	5.11	2,307	6.95	0.0305
2021-02-08	2020-12-31	13F	Bristol Myers Squibb	COM	110122108	34,773	3,843	12.42	2,157	15.66	0.0287
2020-10-30	2020-09-30	13F	Bristol Myers Squibb	COM	110122108	30,930	867	2.88	1,865	5.49	0.0289
2020-08-12	2020-06-30	13F	Bristol Myers Squibb	COM	110122108	30,063	30	0.10	1,768	5.62	0.0310
2020-04-29	2020-03-31	13F	Bristol Myers Squibb	COM	110122108	30,033	-12,766	-29.83	1,674	-39.06	0.0333
2020-02-11	2019-12-31	13F	Bristol Myers Squibb	COM	110122108	42,799	23,523	122.03	2,747	181.17	0.0430
2019-11-08	2019-09-30	13F	Bristol Myers Squibb	COM	110122108	19,276	4,659	31.87	977	47.36	0.0152
2019-07-24	2019-06-30	13F	Bristol Myers Squibb	COM	110122108	14,617	-189	-1.28	663	-6.09	0.0105
2019-05-08	2019-03-31	13F	Bristol Myers Squibb	COM	110122108	14,806	-3,149	-17.54	706	-24.33	0.0116
2019-02-07	2018-12-31	13F	Bristol Myers Squibb	COM	110122108	17,955	-98	-0.54	933	-16.77	0.0185
2018-10-29	2018-09-30	13F	Bristol Myers Squibb	COM	110122108	18,053	2,050	12.81	1,121	26.52	0.0203
2018-08-07	2018-06-30	13F	Bristol Myers Squibb	COM	110122108	16,003	-1,512	-8.63	886	-20.04	0.0169
2018-04-30	2018-03-31	13F	Bristol Myers Squibb	COM	110122108	17,515	1,464	9.12	1,108	12.60	0.0220
2018-02-08	2017-12-31	13F	Bristol Myers Squibb	COM	110122108	16,051	1,724	12.03	984	7.78	0.0200
2017-11-13	2017-09-30	13F	Bristol Myers Squibb	COM	110122108	14,327	4,719	49.12	913	70.65	0.0200
2017-07-24	2017-06-30	13F	Bristol Myers Squibb	COM	110122108	9,608	39	0.41	535	2.88	0.0122
2017-04-28	2017-03-31	13F	Bristol Myers Squibb	COM	110122108	9,569	742	8.41	520	0.78	0.0125
2017-01-24	2016-12-31	13F	Bristol Myers Squibb	COM	110122108	8,827	8,827	0.00	516		0.0135
2016-10-19	2016-09-30	13F	Bristol Myers Squibb	COM	110122108	0	-3,775	-100.00	0	-100.00
2016-07-28	2016-06-30	13F	Bristol Myers Squibb	COM	110122108	3,775	127	3.48	278	19.31	0.0071
2016-04-28	2016-03-31	13F	Bristol Myers Squibb	COM	110122108	3,648	-517	-12.41	233	-18.82	0.0063
2016-02-05	2015-12-31	13F	Bristol Myers Squibb	COM	110122108	4,165	-1,055	-20.21	287	-7.12	0.0087
2015-10-30	2015-09-30	13F	Bristol Myers Squibb	COM	110122108	5,220	1,055	25.33	309	11.55	0.0092
2015-08-12	2015-06-30	13F	Bristol Myers Squibb	COM	110122108	4,165	655	18.66	277	22.57	0.0080
2015-04-20	2015-03-31	13F	Bristol Myers Squibb	COM	110122108	3,510	-10,929	-75.69	226	-69.87	0.0068
2014-05-13	2014-03-31	13F	Bristol Myers Squibb	COM	110122108	14,439	-923	-6.01	750	-8.09	0.0241
2014-02-12	2013-12-31	13F	Bristol Myers Squibb	COM	110122108	15,362	55	0.36	816	15.25	0.0280
2013-10-30	2013-09-30	13F	Bristol Myers Squibb	COM	110122108	15,307	-395	-2.52	708	0.85	0.0266
2013-07-17	2013-06-30	13F	Bristol Myers Squibb	COM	110122108	15,702	15,702		702		0.0275

Legend

Shares: The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value: The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price: The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class: This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred

Allocation (%): The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation: The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%): The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis: The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss: This is the market value of the position as of the effective date minus the cost basis.